In-Cell-Art results with two Top 10 Pharma will be presented at the 16th Annual Discovery on Target on September 25-28 2018 in Boston

Latest Posts

Owkin joins OPTIMA: new research project to improve the treatment of prostate, breast and lung cancer patients using AI

12 October 2021

Owkin is delighted to be part of OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence),... View Article

Hawkcell & Cynbiose team up in a strategic partnership

Cynbiose SAS, a preclinical CRO, and HawkCell, a young innovative company specialized in MRI (Magnetic Resonance Imaging) for small and... View Article

OSE Immunotherapeutics Receives New European Patent Notice of Allowance for Tedopi®

11 October 2021

Further Strengthens Global Intellectual Property Portfolio for Tedopi® until 2038 OSE Immunotherapeutics announced today that it has received notice of... View Article

« Previous 1 … 40 41 42 43 44 … 160 Next »